Could a new pill boost brain power in schizophrenia?
NCT ID NCT07084831
First seen Mar 11, 2026 · Last updated May 21, 2026 · Updated 5 times
Summary
This study tests a new medicine, Xanomeline/Trospium (XT), to see if it can improve thinking and memory in adults with schizophrenia over 24 and 52 weeks. About 171 participants will take XT and have their cognitive skills, symptoms, and quality of life measured. The goal is to find out if XT can help with cognitive problems that current antipsychotics often don't address.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for COGNITIVE IMPAIRMENT are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
AOU Città della Salute e della Scienza di Torino
Torino, 10126, Italy
Contact Email: •••••@•••••
-
Central Institute of Mental Health
Mannheim, 68159, Germany
Contact Email: •••••@•••••
-
Hospital Clínic de Barcelona
Barcelona, 08036, Spain
Contact Email: •••••@•••••
-
Hospital Universitario La Paz
Madrid, 28046, Spain
Contact Email: •••••@•••••
-
Hospital Universitario Virgen del Rocío
Seville, 41013, Spain
Contact Email: •••••@•••••
-
Ludwig Maximilian University
München, 80336, Germany
Contact Email: •••••@•••••
-
Medical University Innsbruck
Innsbruck, 6020, Austria
Contact Email: •••••@•••••
-
National Institute of Mental Health
Klecany, 250 67, Czechia
Contact Email: •••••@•••••
-
Psykiatrisk Center Glostrup
Glostrup Municipality, 2600, Denmark
Contact Email: •••••@•••••
-
Semmelweis University
Budapest, 1083, Hungary
Contact Email: •••••@•••••
-
Sheba Medical Center
Ramat Gan, Israel
Contact Email: •••••@•••••
-
UPC KU Leuven
Leuven, 3070, Belgium
Contact Email: •••••@•••••
-
University Hospital Cologne
Cologne, 50937, Germany
Contact Email: •••••@•••••
-
University Medical Center Groningen
Groningen, Netherlands
Contact Email: •••••@•••••
-
University of Augsburg
Augsburg, 86156, Germany
Contact Email: •••••@•••••
-
University of Campania Luigi Vanvitelli
Naples, 80138, Italy
Contact Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.